Victor Wong

Mr. Victor Wong


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Journal of Endourology
Verified
Journal Article
Closed access
BCBen H. Chew
Ben H. Chew
NSNabil Shalabi
Nabil Shalabi
RHRoman Herout
Roman Herout
ARAlina Reicherz
Alina Reicherz
VWVictor Wong
Victor Wong
NBNaeem Bhojani
Naeem Bhojani
Introduction: Intrarenal pressure is emerging as an important monitoring parameter during flexible ureteroscopy (fURS). We measure how intraoperative conditions affect intrarenal pressure using a novel pressure sensing ureteroscope. Methods: The LithoVue Elite (LVE) single-use digital flexible ureteroscope (Boston Scientific) is the first commercial ureteroscope that senses pressure at its tip. LVE was used in a porcine model to measure intrarenal pressure with and without a ureteral access sheath (UAS) with various sizes and placement locations, irrigation methods, and working channel accessories. LVE pressure accuracy was measured in a bench model. This abstract shows the least-square means from multiway analysis of variances used for analysis. Results: Intrarenal pressures were the highest without a UAS (64 mm Hg), followed by the 11/13 UAS (51 mm Hg) and the 12/14 and 13/15, which were not statistically different (39–40 mm Hg). The pressures were highest with UASs placed at the ureteropelvic junction (61 mm Hg), and lowest if placed in the renal pelvis (24 mm Hg). Irrigation methods showed the highest pressures with syringe (57 mm Hg), while irrigation bags (pressurized at 150–300 mm Hg) produced 43 to 46 mm Hg and 25 mm Hg when applied with 80 cm of gravity. Placing a 200 μm laser fiber reduced pressures from 44 to 41 mm Hg. Finally, the bench model showed that LVE was 96% accurate up to 300 mm Hg. Conclusion: Intrarenal pressure significantly varied based on UAS sizes, placement, and irrigation methods. Accordingly, fURS with LVE is poised to be an invaluable tool for clinical decision-making and future studies of intrarenal pressure.

1 September 2020 in Journal of Endourology
Verified
Journal Article
Closed access
Kymora B. ScotlandKymora B. Scotland
Kymora B. Scotland
VWVictor Wong
Victor Wong
JCJustin Y.H. Chan
Justin Y.H. Chan
ETEhab Rifat Tawfiek
Ehab Rifat Tawfiek
ACAllen Chiura
Allen Chiura
DBDemetrius Bagley
Demetrius Bagley
Introduction: Acquisition costs and prohibitively expensive technical support for endoscope maintenance, repair and reprocessing have deterred adoption of flexible cystoscopes by many urologists internationally. This study evaluated the performance of a novel single use digital cystoscope which can directly connect to a laptop or computer monitor for visualization, obviating the need for a tower. Methods: The performance characteristics of flexible single use cystoscopes (NeoScope) were prospectively evaluated versus a reusable flexible cystoscope (Olympus) in three clinical cases and two independent benchtop testing episodes in Canada. Cystoscope maneuverability, imaging, deflection, irrigation and ease of use of instrumentation were investigated. Additional investigations were performed during clinical use in Zimbabwe (7 patients), Egypt (10 patients) and Dominica (5 patients). Results: Bench testing revealed smaller tip diameter (4.06 vs 6.09 mm) and shorter (35.4 vs 38 cm) single use cystoscopes versus reusable cystoscopes. Deflection of the single use scope was superior with an empty working channel (230 up/220 down) versus the reusable (195 up/95 down) but showed a more substantial decrease in deflection on placement of instruments including a grasper. Clinical use revealed satisfactory maneuverability, ease of use of instruments, deflection and visualization. Conclusions: Benchtop testing performance of the single use digital flexible cystoscopes was inferior compared to reusable digital cystoscopes. However, these single use endoscopes offer adequate illumination, imaging and maneuverability. Direct connection to any computer monitor allowed truly portable use, allowing for treatment of patients in a variety of clinical settings without the need for ancillary equipment.

9 May 2023 in Journal of Endourology
Verified
Journal Article
Closed access
RHRoman Herout
Roman Herout
AHAbdulghafour H Halawani
Abdulghafour H Halawani
VWVictor Wong
Victor Wong
KKKyo Chul Koo
Kyo Chul Koo
TZTianshuang Zhong
Tianshuang Zhong
BCBen H. Chew
Ben H. Chew
Objective: The purpose of this study is to evaluate the current availability of technology for urolithiasis treatment and ureteroscopy. Perioperative practice patterns, availability of ureteroscopic technologies, pre- and post-stenting practices, and methods to alleviate stent-related symptoms were assessed via a survey of members of the Endourological Society. Methods We distributed a 43-question survey online via the Qualtrics platform to members of the Endourological Society. The survey consisted of questions pertaining to the following topics: general (6), equipment (17), preoperative ureteroscopy (URS; 9), intraoperative URS (2), and postoperative URS (9). Results A total of 191 urologists responded to the survey. 51% of urologists were fellowship trained and dedicated an average of 58% of their practice to stone management. In terms of procedures, most urologists performed ureteroscopy most commonly (68%), followed by percutaneous nephrolithotomy (23%) and shockwave lithotripsy (11%). 90% of respondent urologists purchased a new ureteroscope within the last five years (16% single-use scopes, 53% reusable, and 31% purchased both). 57% of the respondents stated that they would be interested in a ureteroscope that can sense intrarenal pressure, with an additional 30% stating they would be interested depending on the cost. 80% of responders purchased a new laser within the last five years, and 59% changed their lasering technique due to the new laser. 70% are performing primary ureteroscopy for obstructing stones, and 30% prefer pre-stenting patients for subsequent URS (on average after 21 days). 59% of responders insert a ureteral stent after URS, which is removed, on average, after eight days in uncomplicated cases and 21 days after complicated URS. Most urologists give analgesics, alpha-blockers, and anticholinergics for stent-related symptoms and less than 10% prescribe opioids. Conclusion Our survey revealed urologists’ eagerness for the early adoption of novel technologies and adherence to conservative practice patterns focused on patient safety.

16 February 2022 in Uro
Verified
Journal Article
Open access
PDF file
VWVictor Wong
Victor Wong
CLColin J. Lundeen
Colin J. Lundeen
RPRyan F. Paterson
Ryan F. Paterson
Kymora B. ScotlandKymora B. Scotland
Kymora B. Scotland
BCBen H. Chew
Ben H. Chew
A retrospective review was conducted to evaluate intraoperative and patient outcomes following simultaneous bilateral percutaneous nephrolithotomy (SB-PCNL). Target stone characteristics, operative time, hospitalization length, post-operative complications, blood loss, opioid use, pain, and stone-free rates were evaluated. In total, 42 patients with large renal stones (>20 mm2) were identified for this study, and 38% of them achieved stone-free status with no residual fragments apparent on post-operative day one CT imaging. The maximum mean residual fragment size was 3.67 mm2 and average number of residual fragments following the procedures was 1.63. The rates of blood loss, post-operative complications, opioid use, and pain from the study cohort were similar to the reported outcomes of studies conducted by others. The potential benefits of a single procedure and anesthesia to treat bilateral stone burdens, lower total pain medication prescribed, and lower hospital costs render SB-PCNL as an attractive option in the treatment of bilateral kidney stones.